CA2284481A1 - Method of producing a subtraction library - Google Patents
Method of producing a subtraction library Download PDFInfo
- Publication number
- CA2284481A1 CA2284481A1 CA002284481A CA2284481A CA2284481A1 CA 2284481 A1 CA2284481 A1 CA 2284481A1 CA 002284481 A CA002284481 A CA 002284481A CA 2284481 A CA2284481 A CA 2284481A CA 2284481 A1 CA2284481 A1 CA 2284481A1
- Authority
- CA
- Canada
- Prior art keywords
- library
- sequences
- dna
- subtraction
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 93
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 72
- 102000004169 proteins and genes Human genes 0.000 claims description 21
- 239000002299 complementary DNA Substances 0.000 claims description 16
- 239000013598 vector Substances 0.000 claims description 16
- 238000012216 screening Methods 0.000 claims description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 9
- 230000014509 gene expression Effects 0.000 claims description 9
- 239000011521 glass Substances 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 230000000644 propagated effect Effects 0.000 claims description 2
- 230000001902 propagating effect Effects 0.000 claims 2
- 238000009396 hybridization Methods 0.000 abstract description 33
- 239000000523 sample Substances 0.000 abstract description 18
- 108020004414 DNA Proteins 0.000 description 31
- 102000040430 polynucleotide Human genes 0.000 description 20
- 108091033319 polynucleotide Proteins 0.000 description 20
- 239000002157 polynucleotide Substances 0.000 description 20
- 239000007787 solid Substances 0.000 description 20
- 108091028043 Nucleic acid sequence Proteins 0.000 description 19
- 239000012634 fragment Substances 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 108090000765 processed proteins & peptides Proteins 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 238000007796 conventional method Methods 0.000 description 9
- 102000053602 DNA Human genes 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 108091034117 Oligonucleotide Proteins 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 230000003321 amplification Effects 0.000 description 6
- 230000027455 binding Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000010561 standard procedure Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 108020004682 Single-Stranded DNA Proteins 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 230000037452 priming Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108091060211 Expressed sequence tag Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241001672648 Vieira Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 150000003377 silicon compounds Chemical class 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000282465 Canis Species 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002186 photoactivation Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 239000002094 self assembled monolayer Substances 0.000 description 1
- 239000013545 self-assembled monolayer Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 101150065190 term gene Proteins 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4168897P | 1997-03-24 | 1997-03-24 | |
| US60/041,688 | 1997-03-24 | ||
| PCT/US1998/005644 WO1998043088A1 (en) | 1997-03-24 | 1998-03-24 | Method of producing a subtraction library |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2284481A1 true CA2284481A1 (en) | 1998-10-01 |
Family
ID=21917812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002284481A Abandoned CA2284481A1 (en) | 1997-03-24 | 1998-03-24 | Method of producing a subtraction library |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1005653A4 (de) |
| JP (1) | JP2002507275A (de) |
| CA (1) | CA2284481A1 (de) |
| WO (1) | WO1998043088A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6638717B2 (en) | 1999-05-19 | 2003-10-28 | Aventis Pharmaceuticals, Inc. | Microarray-based subtractive hybridzation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR910700348A (ko) * | 1988-12-07 | 1991-03-14 | 원본미기재 | 삽입을 함유하는 또는 결실에 해당하는 dna의 풍부화 및 클로닝 방법 |
| EP0533952A4 (en) * | 1991-04-15 | 1993-07-07 | Sumitomo Electric Industries, Ltd. | Process for separating or extracting nucleic acid from specimen containing the same |
| ATE205542T1 (de) * | 1992-03-04 | 2001-09-15 | Univ California | Vergleichende genomhybridisierung |
| US5591575A (en) * | 1993-04-07 | 1997-01-07 | Amersham International Plc | Subtraction hybridization employing aziridinylbenoquinone cross-linking agents |
-
1998
- 1998-03-24 CA CA002284481A patent/CA2284481A1/en not_active Abandoned
- 1998-03-24 EP EP98913043A patent/EP1005653A4/de not_active Withdrawn
- 1998-03-24 JP JP54586898A patent/JP2002507275A/ja active Pending
- 1998-03-24 WO PCT/US1998/005644 patent/WO1998043088A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998043088A1 (en) | 1998-10-01 |
| JP2002507275A (ja) | 2002-03-05 |
| EP1005653A4 (de) | 2004-05-06 |
| EP1005653A1 (de) | 2000-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0743989B1 (de) | Verfahren zum Auffinden von differentiel exprimierte Gene | |
| CA2485968A1 (en) | Method for predicting autoimmune diseases | |
| KR20020008195A (ko) | 폴리뉴클레오티드 서열 변형의 미세배열-기초 분석 | |
| AU2008204338A1 (en) | Circular chromosome conformation capture (4c) | |
| JP2003523183A (ja) | 固相支持体上の複数のポリヌクレオチドを増幅し、検出する方法 | |
| JP2002543856A (ja) | マイクロアレイに基づくサブトラクティブハイブリダイゼーション | |
| JP2001500741A (ja) | 分子配列サインの同定およびそれに関する方法 | |
| EP0405913A2 (de) | Hydrophobe Nukleinsäure-Sonde | |
| EP1358347A2 (de) | Gene, die während der schaumzelldifferenzierung exprimiert werden | |
| US6316608B1 (en) | Combined polynucleotide sequence as discrete assay endpoints | |
| CA2470965A1 (en) | System biology approach: high throughput screening (hts) platforms with multiple dimensions | |
| JP2004517602A (ja) | 複雑性の減少した核酸標的およびその使用方法 | |
| WO1999027090A1 (en) | Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription | |
| JP2006510371A (ja) | ＲＮＡ：ＤＮＡハイブリッドを捕捉、検出及び定量する方法、及びその中で有用な修飾されたＲＮａｓｅＨ | |
| EP1041160A1 (de) | Verfahren zur detektion einer mutation innerhalb einer basensequenz | |
| EP0948646B1 (de) | Verfahren zur identifizierung von essentiellen genen für das wachstum eines organismus | |
| CA2284481A1 (en) | Method of producing a subtraction library | |
| WO2000043538A1 (en) | PROCESS FOR THE GENERATION OF OLIGONUCLEOTIDE LIBRARIES (OLs) REPRESENTATIVE OF GENOMES OR EXPRESSED mRNAs (cDNAs) AND USES THEREOF | |
| TW200404891A (en) | Method for preparation of expressed gene identification cDNA tags and method for analysis of gene expression | |
| CA2374438A1 (en) | Detection system for studying molecular interactions and its preparationand use | |
| WO1998026096A1 (en) | Method for rapid gap closure | |
| JP2002527118A (ja) | ペプチド標識オリゴヌクレオチドを用いた複合核酸集団の操作方法 | |
| US20080076672A1 (en) | Methods for Identifying Genes Essential to the Growth of an Organism | |
| Auesukaree | cDNA microarray technology for the analysis of gene expression | |
| JP2001349889A (ja) | 核酸の分析方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |